Quay Pharmaceuticals has announced that it will relocate Wirral to North Wales to new headquarters and manufacturing facility. The transaction is expected to cost £2.7m.
Quay Pharmaceuticals’ new site will operate in early stage research and development and clinical trials manufacturing for pharmaceutical companies. The new site is reportedly located at Deeside Industrial Park, North Wales.
The company said that the new site in Wales is four times the size of the current premises. The relocation is supported by the Welsh Assembly Government (WAG) and will safeguard 30 jobs.
The company said that the range of support offered by WAG to small and medium-sized businesses had made Wales an attractive proposition for Quay Pharma’s expansion, as reported by Liverpool Daily Post.
The company plans to open in January and is in process currently fitting out laboratories and offices at the new site. The manufacturing operation will be relocated during the first quarter of next year.
Mike Rubinstein, founder, said: “The support from the Assembly Government is great for a small company and of particular help in the current economic climate.
“Not only does it provide advice and access to knowledge but also provides businesses with a high level of promotional and marketing support at overseas events.”